The Max Foundation shared a post on LinekdIn:
“We’re excited to share new research published in “Leukemia” that showcases how innovative diagnostic approaches can expand access to high-quality testing for people living with chronic myeloid leukemia (CML), especially in low- and middle-income countries.
The article, “Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncology,” highlights Spot On CML, a program that, in collaboration with Fred Hutch, is helping make access to CML treatment possible across the globe.
Authors include our board member, Dr. Jerry Radich; Programs Manager Jennifer Rynning, MPH; and Region Head for Latin America, Inés García González, who collaborated hand-in-hand with people living with CML and their families to make this work possible.”
Title: Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncology
Authors: Vivian G. Oehler, Olga Sala-Torra, Neta Gilderman, Lan Beppu, David W. Woolston, Priscilla Namaganda, Jennifer Rynning, Inés García González, Andrea Towlerton, Jenna Voutsinas, Qian Wu, Cecilia C. S. Yeung and Jerald P. Radich
Other articles featuring The Max Foundation on OncoDaily.